scispace - formally typeset
P

Patrícia Cavaco-Silva

Researcher at Instituto Superior de Ciências da Saúde Egas Moniz

Publications -  28
Citations -  855

Patrícia Cavaco-Silva is an academic researcher from Instituto Superior de Ciências da Saúde Egas Moniz. The author has contributed to research in topics: Antibiotics & Antibiotic resistance. The author has an hindex of 15, co-authored 26 publications receiving 676 citations. Previous affiliations of Patrícia Cavaco-Silva include University of Lisbon.

Papers
More filters
Journal ArticleDOI

Clinical and bacteriological survey of diabetic foot infections in Lisbon

TL;DR: Prevalence and precocity of MDR organisms, namely MRSA, were high and were probably related to previous indiscriminate antibiotic use, so clinicians should avoid fluoroquinolones and more frequently consider the use of empirical anti-MRSA therapy.
Journal ArticleDOI

Wound healing potential of topical bacteriophage therapy on diabetic cutaneous wounds

TL;DR: The results suggest that topically administered bacteriophage treatment may be effective in resolving chronic infections, especially when applied in conjunction with wound debridement, and have important implications for the feasibility of using topical antimicrobial therapies to safely treat chronic infections in diabetes mellitus patients.
Journal ArticleDOI

Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections

TL;DR: It is demonstrated that very high concentrations of the most used antibiotics in treating diabetic foot infections (DFI) are required to inhibit S. aureus biofilms in vitro, which may explain why monotherapy with these agents frequently fails to eradicate biofilm infections.
Journal ArticleDOI

Novel chimerical endolysins with broad antimicrobial activity against methicillin-resistant Staphylococcus aureus.

TL;DR: Fusion of endolysin domains of heterologous origin seems to be a suitable approach to design new potent endolysins with changed and/or extended lytic spectrum that are amenable to large-scale production.